Assessment of Salmonella Typhim Vi(TM) vaccine (Sanofi Pasteur MSD) for the investigation of selective antibody deficiency to polysaccharide.
Phase of Trial: Phase IV
Latest Information Update: 22 Nov 2011
At a glance
- Drugs Pneumococcal vaccine; Typhoid vaccine Vi-polysaccharide
- Indications Pneumococcal infections; Typhoid
- Focus Therapeutic Use
- 22 Nov 2011 New trial record